1990—2021年中国5岁以下儿童先天性出生缺陷的疾病负担及未来趋势预测研究

黄冰怡; 赵芹; 彭丹莉; 王曼伊; 赵倩雯

doi:10.7499/j.issn.1008-8830.2408146

PDF(814 KB)

HTML

中国当代儿科杂志 ›› 2025, Vol. 27 ›› Issue (3) : 347-353. DOI: 10.7499/j.issn.1008-8830.2408146

论著·临床研究

1990—2021年中国5岁以下儿童先天性出生缺陷的疾病负担及未来趋势预测研究

黄冰怡¹, 赵芹¹, 彭丹莉², 王曼伊¹, 赵倩雯²

作者信息 +

Burden of congenital birth defects in children under five in China from 1990 to 2021 and prediction of future trend

HUANG Bing-Yi, ZHAO Qin, PENG Dan-Li, WANG Man-Yi, ZHAO Qian-Wen

Author information +

文章历史 +

摘要

目的分析1990—2021年中国5岁以下儿童先天性出生缺陷的发病和疾病负担情况，预测2022—2036年中国5岁以下儿童先天性出生缺陷的发病率，为儿童先天性出生缺陷的预防提供参考。方法利用2021全球疾病负担研究（Global Burden of Disease Study 2021, GBD 2021）数据库，通过发病率和伤残调整生命年（disability-adjusted life year, DALY）等指标描述疾病负担，采用Joinpoint回归模型分析5岁以下儿童先天性出生缺陷发病率及DALY率的变化趋势。采用灰色预测模型GM（1，1）对5岁以下儿童先天性出生缺陷发病率的趋势进行拟合，同时预测2022—2036年5岁以下儿童先天性出生缺陷发病率。结果 2021年中国5岁以下儿童先天性出生缺陷发病率为737.28/10万，其中先天性肌肉骨骼/肢体畸形位居发病率首位（307.15/10万），其次为先天性心脏畸形（223.53/10万）、泌尿生殖道先天畸形（74.99/10万）和消化道先天性畸形（62.61/10万）等。1990—2021年中国5岁以下儿童先天性出生缺陷发病率、DALY率分别以平均每年1.73%和5.42%的速度下降。预测结果显示，2022—2036年中国5岁以下儿童先天性出生缺陷发病率呈现降低的趋势：5岁以下儿童先天性出生缺陷发病率从2022年的892.36/10万降低至2036年的783.35/10万。结论 1990—2021年中国5岁以下儿童先天性出生缺陷的发病率和疾病负担均呈下降趋势；预测未来至2036年，该发病率将持续降低。

Abstract

Objective To study the incidence and disease burden of congenital birth defects in children under five in China from 1990 to 2021 and to predict the incidence of congenital birth defects in this population from 2022 to 2036, providing a reference for the prevention of congenital birth defects in children. Methods Using the Global Burden of Disease Study 2021 (GBD 2021) database, the incidence and disability-adjusted life years (DALY) were employed to describe the disease burden. The Joinpoint regression model was used to analyze the trends in incidence and DALY rates of congenital birth defects in children under five. A grey prediction model GM(1,1) was applied to fit the trend of incidence rates of congenital birth defects in this age group and to predict the incidence from 2022 to 2036. Results In 2021, the incidence rate of congenital birth defects among children under five in China was 737.28 per 100 000. Among these, congenital musculoskeletal and limb deformities had the highest incidence rate at 307.15 per 100 000, followed by congenital heart defects (223.53 per 100 000), congenital urinary and genital tract malformations (74.99 per 100 000), and congenital gastrointestinal malformations (62.61 per 100 000). From 1990 to 2021, the incidence rate and DALY rate of congenital birth defects in children under five in China decreased at an average annual rate of 1.73% and 5.42%, respectively. The prediction analysis indicated a decreasing trend in the incidence of congenital birth defects among children under five in China from 2022 to 2036, with the incidence rate dropping from 892.36 per 100 000 in 2022 to 783.35 per 100 000 in 2036. Conclusions The incidence and disease burden of congenital birth defects in children under five in China showed a significant declining trend from 1990 to 2021. It is predicted that this incidence will continue to decrease until 2036.

导出引用

黄冰怡, 赵芹, 彭丹莉, 王曼伊, 赵倩雯. 1990—2021年中国5岁以下儿童先天性出生缺陷的疾病负担及未来趋势预测研究[J]. 中国当代儿科杂志. 2025, 27(3): 347-353 https://doi.org/10.7499/j.issn.1008-8830.2408146

HUANG Bing-Yi, ZHAO Qin, PENG Dan-Li, WANG Man-Yi, ZHAO Qian-Wen. Burden of congenital birth defects in children under five in China from 1990 to 2021 and prediction of future trend[J]. Chinese Journal of Contemporary Pediatrics. 2025, 27(3): 347-353 https://doi.org/10.7499/j.issn.1008-8830.2408146

参考文献

1 Nelson KB, Bingham P, Edwards EM, et al. Antecedents of neonatal encephalopathy in the Vermont Oxford Network Encephalopathy Registry[J]. Pediatrics, 2012, 130(5): 878-886. PMID: 23071210. PMCID: PMC4074646. DOI: 10.1542/peds.2012-0714.
2 Lynn MK, Aquino MSR, Self SCW, et al. TORCH congenital syndrome infections in Central America's Northern Triangle[J]. Microorganisms, 2023, 11(2): 257. PMID: 36838223. PMCID: PMC9964893. DOI: 10.3390/microorganisms11020257.
3 Kang L, Cao G, Jing W, et al. Global, regional, and national incidence and mortality of congenital birth defects from 1990 to 2019[J]. Eur J Pediatr, 2023, 182(4): 1781-1792. PMID: 36781460. DOI: 10.1007/s00431-023-04865-w.
4 GBD 2019 Under-5 Mortality Collaborators. Global, regional, and national progress towards sustainable development goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the global burden of disease study 2019[J]. Lancet, 2021, 398(10303): 870-905. PMID: 34416195. PMCID: PMC8429803. DOI: 10.1016/S0140-6736(21)01207-1.
5 GBD 2021 Risk Factors Collaborators. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the global burden of disease study 2021[J]. Lancet, 2024, 403(10440): 2162-2203. PMID: 38762324. PMCID: PMC11120204. DOI: 10.1016/S0140-6736(24)00933-4.
6 Kim HJ, Fay MP, Feuer EJ, et al. Permutation tests for joinpoint regression with applications to cancer rates[J]. Stat Med, 2000, 19(3): 335-351. PMID: 10649300. DOI: 10.1002/(sici)1097-0258(20000215)19:3<335::aid-sim336>3.0.co;2-z
7 秦宇辰, 郭威. 年度变化百分比与年均变化百分比在医学研究变化趋势分析中的应用[J]. 中国卫生统计, 2022, 39(3): 470-473. DOI: 10.3969/j.issn.1002-3674.2022.03.036.
8 颜杰, 相丽驰, 方积乾. 灰色预测模型及SAS实现[J]. 中国卫生统计, 2006(1): 75. DOI: 10.3969/j.issn.1002-3674.2006.01.025.
9 Dolan SM, Callaghan WM, Rasmussen SA. Birth defects and preterm birth: overlapping outcomes with a shared strategy for research and prevention[J]. Birth Defects Res A Clin Mol Teratol, 2009, 85(11): 874-878. PMID: 19824057. DOI: 10.1002/bdra.20634.
10 Anderka M, Mai CT, Romitti PA, et al. Development and implementation of the first national data quality standards for population-based birth defects surveillance programs in the United States[J]. BMC Public Health, 2015, 15: 925. PMID: 26386816. PMCID: PMC4575466. DOI: 10.1186/s12889-015-2223-2.
11 Heisey AS, Bell EM, Herdt-Losavio ML, et al. Surveillance of congenital malformations in infants conceived through assisted reproductive technology or other fertility treatments[J]. Birth Defects Res A Clin Mol Teratol, 2015, 103(2): 119-126. PMID: 25684703. DOI: 10.1002/bdra.23355.
12 Boyle B, Addor MC, Arriola L, et al. Estimating global burden of disease due to congenital anomaly: an analysis of European data[J]. Arch Dis Child Fetal Neonatal Ed, 2018, 103(1): F22-F28. PMID: 28667189. PMCID: PMC5750368. DOI: 10.1136/archdischild-2016-311845.
13 United Nations. The millennium development goals report 2015[EB/OL]. [2024-07-25]. https://www.undp.org/sites/g/files/zskgke326/files/publications/es/UNDP_MDG_Report_2015.pdf.
14 Perin J, Mulick A, Yeung D, et al. Global, regional, and national causes of under-5 mortality in 2000-19: an updated systematic analysis with implications for the sustainable development goals[J]. Lancet Child Adolesc Health, 2022, 6(2): 106-115. PMID: 34800370. PMCID: PMC8786667. DOI: 10.1016/S2352-4642(21)00311-4.
15 Michalski AM, Richardson SD, Browne ML, et al. Sex ratios among infants with birth defects, national birth defects prevention study, 1997-2009[J]. Am J Med Genet A, 2015, 167A(5): 1071-1081. PMID: 25711982. DOI: 10.1002/ajmg.a.36865.
16 Eriksson JG, Kajantie E, Osmond C, et al. Boys live dangerously in the womb[J]. Am J Hum Biol, 2010, 22(3): 330-335. PMID: 19844898. PMCID: PMC3923652. DOI: 10.1002/ajhb.20995.
17 Clifton VL. Review: sex and the human placenta: mediating differential strategies of fetal growth and survival[J]. Placenta, 2010, 31 (Suppl): S33-S39. PMID: 20004469. DOI: 10.1016/j.placenta.2009.11.010.
18 Barker DJ. Fetal origins of coronary heart disease[J]. Br Heart J, 1993, 69(3): 195-196. PMID: 8461215. PMCID: PMC1024978. DOI: 10.1136/hrt.69.3.195.
19 Marengo LK, Flood TJ, Ethen MK, et al. Study of selected birth defects among American Indian/Alaska Native population: a multi-state population-based retrospective study, 1999-2007[J]. Birth Defects Res, 2018, 110(19): 1412-1418. PMID: 30403007. PMCID: PMC6425493. DOI: 10.1002/bdr2.1397.
20 Carmichael SL. Birth defects epidemiology[J]. Eur J Med Genet, 2014, 57(8): 355-358. PMID: 24657225. DOI: 10.1016/j.ejmg.2014.03.002.
21 孙海波. 环境污染对妊娠结局影响的研究进展[J]. 职业与健康, 2015, 31(15): 2144-2146. DOI: 10.13329/j.cnki.zyyjk.2015.0746.
22 Ravindra K, Chanana N, Mor S. Exposure to air pollutants and risk of congenital anomalies: a systematic review and metaanalysis[J]. Sci Total Environ, 2021, 765: 142772. PMID: 33183823. DOI: 10.1016/j.scitotenv.2020.142772.
23 Castoldi AF, Johansson C, Onishchenko N, et al. Human developmental neurotoxicity of methylmercury: impact of variables and risk modifiers[J]. Regul Toxicol Pharmacol, 2008, 51(2): 201-214. PMID: 18367301. DOI: 10.1016/j.yrtph.2008.01.016.
24 Harris BS, Bishop KC, Kemeny HR, et al. Risk factors for birth defects[J]. Obstet Gynecol Surv, 2017, 72(2): 123-135. PMID: 28218773. DOI: 10.1097/OGX.0000000000000405.
25 Cleary-Goldman J, Malone FD, Vidaver J, et al. Impact of maternal age on obstetric outcome[J]. Obstet Gynecol, 2005, 105(5 Pt 1): 983-990. PMID: 15863534. DOI: 10.1097/01.AOG.0000158118.75532.51.
26 Kerr SM, Van Bennekom CM, Mitchell AA. Tetanus, diphtheria, and pertussis vaccine (Tdap) in pregnancy and risk of major birth defects in the offspring[J]. Birth Defects Res, 2020, 112(5): 393-403. PMID: 31903700. DOI: 10.1002/bdr2.1642.
27 Eskes TK. Possible basis for primary prevention of birth defects with folic acid[J]. Fetal Diagn Ther, 1994, 9(3): 149-154. PMID: 8060509. DOI: 10.1159/000263923.
28 Streissguth AP, Bookstein FL, Barr HM, et al. Risk factors for adverse life outcomes in fetal alcohol syndrome and fetal alcohol effects[J]. J Dev Behav Pediatr, 2004, 25(4): 228-238. PMID: 15308923. DOI: 10.1097/00004703-200408000-00002.
29 Maktabi MA, Vossaert L, Van den Veyver IB. Cell-based noninvasive prenatal testing (cbNIPT): a review on the current developments and future prospects[J]. Clin Obstet Gynecol, 2023, 66(3): 636-648. PMID: 37650673. PMCID: PMC10491429. DOI: 10.1097/GRF.0000000000000798.
30 Moufarrej MN, Bianchi DW, Shaw GM, et al. Noninvasive prenatal testing using circulating DNA and RNA: advances, challenges, and possibilities[J]. Annu Rev Biomed Data Sci, 2023, 6: 397-418. PMID: 37196360. PMCID: PMC10528197. DOI: 10.1146/annurev-biodatasci-020722-094144.
31 李华锋, 徐从红, 冯桐, 等. 无创产前基因检测筛查胎儿染色体异常的临床应用价值[J]. 检验医学与临床, 2024, 21(8): 1087-1091. DOI: 10.3969/j.issn.1672-9455.2024.08.013.
32 温雪恒, 翟巾帼, 熊安琪, 等. 全球群组化母婴保健的现状及启示[J]. 中国护理管理, 2021, 21(11): 1720-1724. DOI: 10.3969/j.issn.1672-1756.2021.11.025.
33 Sharma J, O'Connor M, Rima Jolivet R. Group antenatal care models in low- and middle-income countries: a systematic evidence synthesis[J]. Reprod Health, 2018, 15(1): 38. PMID: 29506531. PMCID: PMC5836451. DOI: 10.1186/s12978-018-0476-9.